Viking Therapeutics
VKTX
#3774
Rank
NZ$6.12 B
Marketcap
NZ$52.79
Share price
0.68%
Change (1 day)
14.07%
Change (1 year)

Annual Reports (10-K)

Latest form 10-K annual reports for Viking Therapeutics CIK: 0001607678

Thumbnail Viking Therapeutics
 10-K Annual Report

10-K Annual Report 2026-02-11

Language: English

View Annual Report (10-K)
Thumbnail Viking Therapeutics
 10-K Annual Report

10-K Annual Report 2025-02-26

Language: English

View Annual Report (10-K)
Thumbnail Viking Therapeutics
 10-K Annual Report

10-K Annual Report 2024-02-07

Language: English

View Annual Report (10-K)
Thumbnail Viking Therapeutics
 10-K Annual Report

10-K Annual Report 2023-02-10

Language: English

View Annual Report (10-K)
Thumbnail Viking Therapeutics
 10-K Annual Report

10-K Annual Report 2022-02-09

Language: English

View Annual Report (10-K)
Thumbnail Viking Therapeutics
 10-K Annual Report

10-K Annual Report 2021-02-17

Language: English

View Annual Report (10-K)
Thumbnail Viking Therapeutics
 10-K Annual Report

10-K Annual Report 2020-02-26

Language: English

View Annual Report (10-K)
Thumbnail Viking Therapeutics
 10-K Annual Report

10-K Annual Report 2019-03-13

Language: English

View Annual Report (10-K)
Thumbnail Viking Therapeutics
 10-K Annual Report

10-K Annual Report 2018-03-07

Language: English

View Annual Report (10-K)
Thumbnail Viking Therapeutics
 10-K Annual Report

10-K Annual Report 2017-03-21

Language: English

View Annual Report (10-K)
Thumbnail Viking Therapeutics
 10-K Annual Report

10-K Annual Report 2016-03-08

Language: English

View Annual Report (10-K)